Format
Sort by

Send to

Choose Destination

Search results

Items: 14

1.

Prognostic value of thyroid-stimulating hormone within reference range in patients with coronary artery disease.

Ndrepepa G, Braun S, Mayer K, Cassese S, Fusaro M, Byrne RA, Hoppmann P, Schunkert H, Laugwitz KL, Kastrati A.

Metabolism. 2015 Oct;64(10):1308-15. doi: 10.1016/j.metabol.2015.07.009.

PMID:
26298467
2.

Thyroid hormones and coronary artery calcification in euthyroid men and women.

Zhang Y, Kim BK, Chang Y, Ryu S, Cho J, Lee WY, Rhee EJ, Kwon MJ, Rampal S, Zhao D, Pastor-Barriuso R, Lima JA, Shin H, Guallar E.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2128-34. doi: 10.1161/ATVBAHA.114.303889.

3.

Normal thyroid-stimulating hormone levels, autoimmune activation, and coronary heart disease risk.

Onat A, Aydın M, Can G, Çelik E, Altay S, Karagöz A, Ademoğlu E.

Endocrine. 2015 Feb;48(1):218-26. doi: 10.1007/s12020-014-0269-z.

PMID:
24794068
4.
5.

Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway.

Asvold BO, Bjøro T, Platou C, Vatten LJ.

Clin Endocrinol (Oxf). 2012 Dec;77(6):911-7. doi: 10.1111/j.1365-2265.2012.04477.x.

PMID:
22724581
6.

Mortality and coronary heart disease in euthyroid patients.

Pereg D, Tirosh A, Elis A, Neuman Y, Mosseri M, Segev D, Lishner M, Hermoni D.

Am J Med. 2012 Aug;125(8):826.e7-12. doi: 10.1016/j.amjmed.2011.11.023.

7.

A high normal TSH level is associated with an atherogenic lipid profile in euthyroid non-smokers with newly diagnosed asymptomatic coronary heart disease.

Wanjia X, Chenggang W, Aihong W, Xiaomei Y, Jiajun Z, Chunxiao Y, Jin X, Yinglong H, Ling G.

Lipids Health Dis. 2012 Mar 27;11:44. doi: 10.1186/1476-511X-11-44.

8.

Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study.

Asvold BO, Bjøro T, Nilsen TI, Gunnell D, Vatten LJ.

Arch Intern Med. 2008 Apr 28;168(8):855-60. doi: 10.1001/archinte.168.8.855.

PMID:
18443261
9.

Levothyroxine replacement therapy in patients with subclinical hypothyroidism and coronary artery disease.

Fadeyev VV, Sytch J, Kalashnikov V, Rojtman A, Syrkin A, Melnichenko G.

Endocr Pract. 2006 Jan-Feb;12(1):5-17.

PMID:
16524858
10.

Is subclinical hypothyroidism associated with hyperhomocysteinemia?

Aldasouqi S, Nkansa-Dwamena D, Bokhari S, Alzahrani AS, Khan M, Al-Reffi A, Merdad A.

Endocr Pract. 2004 Sep-Oct;10(5):399-403.

PMID:
15760786
11.

Homocysteine concentrations in subclinical hypothyroidism.

Sengül E, Cetinarslan B, Tarkun I, Cantürk Z, Türemen E.

Endocr Res. 2004 Aug;30(3):351-9.

PMID:
15554351
12.

Homocysteine, hypothyroidism, and effect of thyroid hormone replacement.

Catargi B, Parrot-Roulaud F, Cochet C, Ducassou D, Roger P, Tabarin A.

Thyroid. 1999 Dec;9(12):1163-6.

PMID:
10646653
13.

Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects.

de Bruin TW, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries AR, Akveld MJ, Erkelens DW.

J Clin Endocrinol Metab. 1993 Jan;76(1):121-6.

PMID:
8421075
14.

Chronic administration of amiodarone and thyroid function: a follow-up study.

Sanmartí A, Permanyer-Miralda G, Castellanos JM, Foz-Sala M, Galard RM, Soler-Soler J.

Am Heart J. 1984 Nov;108(5):1262-8.

PMID:
6496285
Items per page

Supplemental Content

Loading ...
Support Center